Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Westervelt

Showing results (231-240 of 359) with videos related to

Pageof 36
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|November 20, 2023
Transition to Residency: National Study of Factors Contributing to Variability in Learner Milestones Ratings in Emergency Medicine and Family MedicineYoon Soo Park, Michael S Ryan, Sean O Hogan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2016
Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell TransplantIbraheem H Motabi, Armin Ghobadi, Jingxia Liu, et al.
PNAS Nexus|September 4, 2025
A graph theory-based algorithm for the reduction of atmospheric chemical mechanismsForwood Wiser, Siddhartha Sen, Zhizhao Wang, et al.
American Journal of Hematology|January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemiaMeagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Leukemia & Lymphoma|April 29, 2016
A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndromeMathew A Cherian, Raoul Tibes, Feng Gao, et al.
Blood|November 6, 2010
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemiaTodd A Fehniger, Geoffrey L Uy, Kathryn Trinkaus, et al.
Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.
Transplantation and Cellular Therapy|May 22, 2022
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related MortalityLawrence Wayne Liu, Alicia Yn, Feng Gao, et al.
JAMIA Open|April 25, 2024
Analysis of laboratory data transmission between two healthcare institutions using a widely used point-to-point health information exchange platform: a case reportHung S Luu, Walter S Campbell, Raja A Cholan, et al.
American Journal of Hematology|August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromesMike G Martin, Richard A Walgren, Elizabeth Procknow, et al.
Pageof 36

Showing results (231-240 of 359) with videos related to

Sort By:
Pageof 36
Academic Medicine : Journal of the Association of American Medical Colleges|November 20, 2023
Transition to Residency: National Study of Factors Contributing to Variability in Learner Milestones Ratings in Emergency Medicine and Family MedicineYoon Soo Park, Michael S Ryan, Sean O Hogan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2016
Chemotherapy versus Hypomethylating Agents for the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome after Allogeneic Stem Cell TransplantIbraheem H Motabi, Armin Ghobadi, Jingxia Liu, et al.
PNAS Nexus|September 4, 2025
A graph theory-based algorithm for the reduction of atmospheric chemical mechanismsForwood Wiser, Siddhartha Sen, Zhizhao Wang, et al.
American Journal of Hematology|January 14, 2014
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemiaMeagan A Jacoby, Michael G Martin, Geoffrey L Uy, et al.
Leukemia & Lymphoma|April 29, 2016
A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndromeMathew A Cherian, Raoul Tibes, Feng Gao, et al.
Blood|November 6, 2010
A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemiaTodd A Fehniger, Geoffrey L Uy, Kathryn Trinkaus, et al.
Bone Marrow Transplantation|July 29, 2014
A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myelomaT-F Wang, M A Fiala, A F Cashen, et al.
Transplantation and Cellular Therapy|May 22, 2022
Letermovir Discontinuation at Day 100 After Allogeneic Stem Cell Transplant Is Associated With Increased CMV-Related MortalityLawrence Wayne Liu, Alicia Yn, Feng Gao, et al.
JAMIA Open|April 25, 2024
Analysis of laboratory data transmission between two healthcare institutions using a widely used point-to-point health information exchange platform: a case reportHung S Luu, Walter S Campbell, Raja A Cholan, et al.
American Journal of Hematology|August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromesMike G Martin, Richard A Walgren, Elizabeth Procknow, et al.
Pageof 36